Brian Strem
Directeur Général chez KIORA PHARMACEUTICALS, INC.
Fortune : 50 828 $ au 31/05/2024
Postes actifs de Brian Strem
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Directeur Général | 26/07/2021 | - |
| Directeur/Membre du Conseil | 26/07/2021 | - | |
| President | 26/07/2021 | - | |
| Comptroller/Controller/Auditor | 16/06/2022 | - | |
| Directeur Financier/CFO | 16/06/2022 | - | |
Okogen, Inc.
 Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Directeur/Membre du Conseil | 01/06/2015 | - |
| Directeur Financier/CFO | - | - | |
| Fondateur | - | - | |
| Secrétaire Général | - | - | |
Yellowbrick Bio LLC
 Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Directeur/Membre du Conseil | 01/01/2020 | - |
| Fondateur | 01/01/2020 | - | |
| Corporate Officer/Principal | - | - | |
| Bayon Therapeutics, Inc. | Directeur/Membre du Conseil | - | - |
| Fondateur | - | - |
Historique de carrière de Brian Strem
Formation de Brian Strem
| University of California, Los Angeles | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Director/Board Member | 4 |
| Founder | 3 |
| Director of Finance/CFO | 2 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Okogen, Inc.
Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Commercial Services |
Yellowbrick Bio LLC
Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Health Technology |
| Bayon Therapeutics, Inc. |
- Bourse
- Insiders
- Brian Strem
- Expérience
